Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Rev Bras Parasitol Vet ; 29(4): e010520, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33263615

RESUMO

Cattle tick fever (CTF) causes significant economic losses in the livestock sector. The pathogenic action of the hemoparasites is associated with anemia, weight loss, abortion and reduced productivity, which result with animal death. Programs to prevent CTF involve several procedures, including immunization, chemoprophylaxis and use of ectoparasiticides, together with the vector control in the environment. The objective of this study was to report an acute outbreak of CTF in a group of 157 Hereford cattle from a farm without presence of the vector, that were moved to a farm in the same state with a high tick infestation (Rhipicephalus microplus). On the day before the transportation, the animals received a chemoprophylaxis with imidocarb dipropionate (3 mg/kg, SC), which was repeated 21 days after the first application. After 42 days, some animals showed signs compatible with CTF, which was confirmed through clinical examination, necropsy, histopathological and hemoparasitological analyses. The morbidity rate was 37.6% and the mortality rate was 24.8%. Calves that were recently weaned were the group most affected with the tick fever, morbidity (100% and mortality (73%). Chemoprophylaxis in association with use of ectoparasiticides was not sufficient to control the outbreak of the disease.


Assuntos
Anaplasmose , Babesiose , Doenças dos Bovinos , Quimioprevenção/veterinária , Infestações por Carrapato , Anaplasmose/diagnóstico , Anaplasmose/epidemiologia , Anaplasmose/prevenção & controle , Animais , Babesiose/diagnóstico , Babesiose/epidemiologia , Babesiose/prevenção & controle , Bovinos , Doenças dos Bovinos/prevenção & controle , Rhipicephalus , Infestações por Carrapato/prevenção & controle , Infestações por Carrapato/veterinária
2.
Poult Sci ; 99(4): 1978-1982, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32241479

RESUMO

Histomoniasis, caused by the protozoan parasite Histomonas meleagridis, is a disease to which turkeys are especially susceptible. Currently, no chemoprophylaxis compounds are available to mitigate this disease. Boric acid (BA) exhibits antifungal, antiseptic, and antiviral properties and has been used in the treatment of yeast infections. Based on these characteristics, an experiment was conducted to evaluate whether BA might be an efficacious prophylaxis against challenge with wild-type H. meleagridis (WTH). On day-of-hatch, poults were randomly assigned to either a basal control diet or a BA diet (basal diet + 0.2% BA). Groups consisted of a nonchallenged control (NC; basal diet), 0.2% BA + challenge (BA; 0.2% BA diet), and a positive-challenged control (PC; basal diet). On day 21, challenged groups were intracloacally inoculated with 2 × 105 WTH cells/turkey, and lesions were evaluated on day 14 postchallenge. Individual body weights were recorded on day 0, 21, and 35 to calculate the prechallenge and postchallenge body weight gain (BWG). The BA group resulted in lower prechallenge day 0 to day 21 BWG (P = 0.0001) than the NC group. Postchallenge day 21 to day 35, BWG was also lower (P = 0.0503) in the BA group than the PC group. No differences between the BA and PC groups were detected for mortalities associated with histomoniasis. Moreover, liver and cecal lesions were not statistically different between the BA and PC groups. Taken together, these data suggest that BA was not efficacious in the prevention or reduction of histomoniasis disease severity when provided at 0.2% dietary concentration under these experimental conditions.


Assuntos
Antiparasitários/farmacologia , Ácidos Bóricos/farmacologia , Doenças das Aves Domésticas/prevenção & controle , Infecções Protozoárias em Animais/prevenção & controle , Trichomonadida/efeitos dos fármacos , Perus , Animais , Quimioprevenção/veterinária , Feminino , Doenças das Aves Domésticas/parasitologia , Infecções Protozoárias em Animais/parasitologia
3.
Rev. bras. parasitol. vet ; 29(4): e010520, 2020. graf
Artigo em Inglês | LILACS | ID: biblio-1144235

RESUMO

Abstract Cattle tick fever (CTF) causes significant economic losses in the livestock sector. The pathogenic action of the hemoparasites is associated with anemia, weight loss, abortion and reduced productivity, which result with animal death. Programs to prevent CTF involve several procedures, including immunization, chemoprophylaxis and use of ectoparasiticides, together with the vector control in the environment. The objective of this study was to report an acute outbreak of CTF in a group of 157 Hereford cattle from a farm without presence of the vector, that were moved to a farm in the same state with a high tick infestation (Rhipicephalus microplus). On the day before the transportation, the animals received a chemoprophylaxis with imidocarb dipropionate (3 mg/kg, SC), which was repeated 21 days after the first application. After 42 days, some animals showed signs compatible with CTF, which was confirmed through clinical examination, necropsy, histopathological and hemoparasitological analyses. The morbidity rate was 37.6% and the mortality rate was 24.8%. Calves that were recently weaned were the group most affected with the tick fever, morbidity (100% and mortality (73%). Chemoprophylaxis in association with use of ectoparasiticides was not sufficient to control the outbreak of the disease.


Resumo A "tristeza parasitária bovina" (TPB) gera importantes perdas econômicas na bovinocultura mundial. A ação patogênica dos hemoparasitas resulta em anemia, perda de peso, abortos e diminuição da produtividade, culminando, muitas vezes, em óbito dos animais. Um programa de prevenção para TPB necessita de medidas integradas, como a imunização, quimioprofilaxia e utilização de ectoparasiticidas, em conjunto com ações que visem ao controle ambiental dos vetores. Este artigo tem em vista o relato de um surto de TPB em uma fazenda de produção de bovinos de corte e com alta infestação do carrapato (Rhipicephalus microplus). A fazenda adquiriu 157 animais puros de origem, da raça Hereford, proveniente de uma fazenda sem presença do vetor. No dia anterior ao transporte, os animais receberam quimioprofilaxia com dipropionato de imidocarb (3mg/Kg/SC), repetindo-se 21 dias após a primeira aplicação. Aos 42 dias, alguns bezerros manifestaram sinais clínicos compatíveis com TPB, sendo confirmado pelo exame clínico, necropsia, análises histopatológicas e hemoparasitológicas. A morbidade foi de 37,6% (59/157), e a letalidade de 24,8% (39/157). A categoria de bezerros recém desmamados foi a mais acometida, com morbidade de 100% (52/52) e letalidade de 73% (38/52). A quimioprofilaxia associada à utilização de ectoparasiticidas foram insuficientes para evitar a ocorrência do surto da enfermidade.


Assuntos
Animais , Babesiose/diagnóstico , Babesiose/prevenção & controle , Babesiose/epidemiologia , Anaplasmose/diagnóstico , Anaplasmose/prevenção & controle , Anaplasmose/epidemiologia , Infestações por Carrapato/prevenção & controle , Infestações por Carrapato/veterinária , Bovinos , Doenças dos Bovinos/prevenção & controle , Quimioprevenção/veterinária , Rhipicephalus
4.
Acta amaz ; 49(2): 145-151, abr. - jun. 2019. tab
Artigo em Inglês | LILACS, VETINDEX | ID: biblio-1119166

RESUMO

The skin secretion from toads of the Bufonidae family has great potential in the search for new active compounds to be used as drug candidates in treating some diseases, among them cancer. In this context, this study aimed to evaluate the cytotoxic and antimutagenic activity of the parotoid gland secretion extracts of Rhinella marina and Rhaebo guttatus, as well as biochemically analyze transaminases and serum creatinine for liver and renal damage, respectively. Cytotoxicity was performed by the colorimetric method based on MTT (3- [4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide) with different concentrations of the extracts in Walker or splenic tumor cell cultures from rats and mice. The micronucleus test was performed with male Swiss mice treated orally with the extracts for 15 days, and then intraperitoneally with N-ethyl-N-nitrosurea (50 mg kg-1). Micronucleated polychromatic erythrocytes (MNPCE) were evaluated in bone marrow. The extracts showed cytotoxic activity in the evaluated cells. There was a significant reduction in the frequency of MNPCE (R. marina = 56% and R. guttatus = 75%, p < 0.001), indicating antimutagenic potential of the extracts. The groups treated only with extract showed an increase in MNPCE frequency, evidencing mutagenic potential. Biochemical analyzes showed no significant difference between treatments. Thus, under our experimental conditions, the extracts of R. marina and R. guttatus skin secretions presented chemopreventive potential for cancer. (AU)


A secreção cutânea de anuros da família Bufonidae tem grande potencial na busca de novos compostos ativos para utilização como fármacos candidatos no tratamento de algumas doenças, entre elas o câncer. Neste contexto, este estudo teve como objetivo avaliar a atividade citotóxica e antimutagênica dos extratos da secreção da glândula parótida de Rhinella marina e Rhaebo guttatus, bem como a análise bioquímica de transaminases e creatinina séricas, para avaliar dano hepático e renal, respectivamente. A avaliação de citotoxicidade foi realizada pelo método colorimétrico baseado no MTT (3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-tetrazolium bromide), com diferentes concentrações dos extratos em culturas de células do Tumor de Walker ou células esplênicas de rato e camundongo. O teste do micronúcleo foi realizado com camundongos Swiss machos que receberam tratamento oral com os extratos durante 15 dias, seguido de tratamento intraperitoneal com N-etil-N-nitrosuréia (50 mg kg-1). A frequência de eritrócitos policromáticos micronucleados (PCEMN) foi determinada em medula óssea. Os extratos apresentaram ação citotóxica nas células avaliadas. Houve uma redução significativa na frequência de PCEMN (R. marina = 56% e R. guttatus = 75%, p < 0,001), observando-se um potencial antimutagênico dos extratos. Os grupos tratados somente com os extratos apresentaram um aumento na frequência de PCEMNs, evidenciando um potencial mutagênico. As análises bioquímicas não apresentaram diferença significativa entre os tratamentos. Assim, nas condições experimentais testadas, as secreções cutâneas de R. marina e R. guttatus apresentaram potencial quimiopreventivo para câncer.(AU)


Assuntos
Animais , Camundongos , Bufonidae/fisiologia , Antimutagênicos/análise , Citotoxinas/análise , Glândula Parótida/química , Quimioprevenção/veterinária , Bioprospecção
5.
Poult Sci ; 96(6): 1901-1909, 2017 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-27915270

RESUMO

The hen is an attractive animal model for in vivo testing of agents that thwart ovarian carcinogenesis because ovarian cancer in the domestic hen features clinical and molecular alterations that are similar to ovarian cancer in humans, including a high incidence of p53 mutations. The objective of the study was to test the potential ovarian cancer chemopreventive effect of the p53 stabilizing compound CP-31398 on hens that spontaneously present the ovarian cancer phenotype. Beginning at 79 wk of age, 576 egg-laying hens (Gallus domesticus) were randomized to diets containing different amounts of CP-31398 for 94 wk, 5 d, comprising a control group (C) (n = 144), which was fed a diet containing 0 ppm (mg/kg) of CP-31398; a low-dose treatment (LDT) group (n = 144), which was fed a diet containing 100 ppm of CP-31398; a moderate-dose treatment (MDT) group (n = 144) which was fed a diet containing 200 ppm of CP-31398; and a high-dose treatment (HDT) group (n = 144), which was fed a diet containing 300 ppm of CP-31398. Hens were killed at 174 wk of age to determine the incidence of ovarian and oviductal adenocarcinomas. Whereas the incidence of localized and metastatic ovarian cancers in the MDT and HDT groups was significantly lower (up to 77%) compared to levels in the C and LDT groups (P < 0.05), the incidence of oviductal cancer was unaffected by CP-31398. CP-31398 appears to be an effective tool for chemoprevention against ovarian malignancies, but does not appear to affect oviductal malignancies.


Assuntos
Adenocarcinoma/prevenção & controle , Adenocarcinoma/veterinária , Quimioprevenção/veterinária , Neoplasias Ovarianas/prevenção & controle , Neoplasias Ovarianas/veterinária , Pirimidinas/farmacologia , Ração Animal/análise , Animais , Galinhas , Dieta/veterinária , Feminino , Genes p53/efeitos dos fármacos , Neoplasias dos Genitais Femininos/prevenção & controle , Neoplasias dos Genitais Femininos/veterinária , Oviductos/patologia , Oviposição , Pirimidinas/administração & dosagem
6.
Vet Parasitol ; 210(3-4): 167-78, 2015 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-25936435

RESUMO

Macrocyclic lactone (ML) endectocides are used as chemoprophylaxis for heartworm infection (Dirofilaria immitis) in dogs and cats. Claims of loss of efficacy (LOE) of ML heartworm preventives have become common in some locations in the USA. We directly tested whether resistance to MLs exists in LOE isolates of D. immitis and identified genetic markers that are correlated with, and therefore can predict ML resistance. ML controlled studies showed that LOE strains of D. immitis established infections in dogs despite chemoprophylaxis with oral ivermectin or injectable moxidectin. A whole genome approach was used to search for loci associated with the resistance phenotype. Many loci showed highly significant differences between pools of susceptible and LOE D. immitis. Based on 186 potential marker loci, Sequenom(®) SNP frequency analyses were conducted on 663 individual parasites (adult worms and microfilariae) which were phenotypically characterized as susceptible (SUS), confirmed ML treatment survivors/resistant (RES), or suspected resistant/loss of efficacy (LOE) parasites. There was a subset of SNP loci which appears to be promising markers for predicting ML resistance, including SNPs in some genes that have been associated with ML resistance in other parasites. These data provide unequivocal proof of ML resistance in D. immitis and identify genetic markers that could be used to monitor for ML resistance in heartworms.


Assuntos
Dirofilaria immitis/genética , Dirofilariose/parasitologia , Doenças do Cão/parasitologia , Filaricidas/farmacologia , Lactonas/farmacologia , Animais , Quimioprevenção/veterinária , Dirofilaria immitis/efeitos dos fármacos , Cães , Resistência a Medicamentos , Feminino , Marcadores Genéticos/genética , Ivermectina/farmacologia , Macrolídeos/farmacologia , Masculino , Microfilárias , Polimorfismo de Nucleotídeo Único/genética
7.
Res Vet Sci ; 97(2): 274-81, 2014 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-24997556

RESUMO

Turkeys are extremely sensitive to aflatoxin B1 (AFB1) which causes decreased growth, immunosuppression and liver necrosis. The purpose of this study was to determine whether probiotic Lactobacillus, shown to be protective in animal and clinical studies, would likewise confer protection in turkeys, which were treated for 11 days with either AFB1 (AFB; 1 ppm in diet), probiotic (PB; 1 × 10(11) CFU/ml; oral, daily), probiotic + AFB1 (PBAFB), or PBS control (CNTL). The AFB1 induced drop in body and liver weights were restored to normal in CNTL and PBAFB groups. Hepatotoxicity markers were not significantly reduced by probiotic treatment. Major histocompatibility complex (MHC) genes BG1 and BG4, which are differentially expressed in liver and spleens, were not significantly affected by treatments. These data indicate modest protection, but the relatively high dietary AFB1 treatment, and the extreme sensitivity of this species may reveal limits of probiotic-based protection strategies.


Assuntos
Aflatoxina B1/toxicidade , Doenças Transmitidas por Alimentos/veterinária , Lactobacillus , Complexo Principal de Histocompatibilidade/efeitos dos fármacos , Micotoxicose/veterinária , Doenças das Aves Domésticas/prevenção & controle , Probióticos/farmacologia , Probióticos/uso terapêutico , Aflatoxina B1/administração & dosagem , Animais , Quimioprevenção/métodos , Quimioprevenção/veterinária , Dieta/efeitos adversos , Doenças Transmitidas por Alimentos/patologia , Doenças Transmitidas por Alimentos/prevenção & controle , Fígado/efeitos dos fármacos , Fígado/patologia , Complexo Principal de Histocompatibilidade/genética , Micotoxicose/patologia , Micotoxicose/prevenção & controle , Tamanho do Órgão/efeitos dos fármacos , Doenças das Aves Domésticas/imunologia , Doenças das Aves Domésticas/patologia , Especificidade da Espécie , Baço/efeitos dos fármacos , Baço/patologia , Resultado do Tratamento , Perus
8.
Vet Pathol ; 46(4): 576-88, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19276067

RESUMO

Canine cancer has become more prevalent in recent years because of increased life expectancy and greater attention to the health of pets. The range of cancers seen in dogs is as diverse as that in human patients, and despite more intensive therapeutic interventions, fatality rates remain unacceptably high in both species. Chemoprevention is therefore an important means of confronting this disease. Because domestic pets share our environment, greater cross-application and study of the protumorigenic and antitumorigenic factors in our shared environment will benefit all species, leading to the development of new families of less toxic antitumorigenic compounds based on novel and established molecular targets. Currently, the most interesting cancer preventive agents are nonsteroidal anti-inflammatory drugs, peroxisome proliferator-activated receptor-gamma ligands, and dietary compounds. This article provides an overview of what is known about how these agents affect molecular signaling in neoplastic disease, with reference to reported application and/or study in dogs where available.


Assuntos
Anti-Inflamatórios não Esteroides/farmacologia , Quimioprevenção/veterinária , Doenças do Cão/prevenção & controle , Neoplasias/veterinária , Transdução de Sinais/efeitos dos fármacos , Animais , Quimioprevenção/métodos , Ciclo-Oxigenase 1/metabolismo , Ciclo-Oxigenase 2/metabolismo , Suplementos Nutricionais , Cães , Proteína 1 de Resposta de Crescimento Precoce/metabolismo , Ligantes , Estrutura Molecular , Neoplasias/prevenção & controle , PPAR gama/metabolismo , Transdução de Sinais/fisiologia
10.
Vet Rec ; 141(17): 441-5, 1997 Oct 25.
Artigo em Inglês | MEDLINE | ID: mdl-9369002

RESUMO

The influence of chemoprophylaxis with an ivermectin sustained-release bolus in the first grazing season on the resistance of cattle to gastrointestinal nematodes during the following grazing season was investigated. In 1993 and 1994 dairy replacement calves were either given one bolus at the start of their first grazing season or left untreated. The two groups were grazed separately on a pasture that was divided into two similar sized paddocks. Faecal egg counts, serum pepsinogen and antibody levels were measured to evaluate host-parasite contact. Pasture infection levels were estimated by pasture larval counts and worm counts in tracer calves. After winter housing the animals were monitored during their second grazing season on a pasture that was also divided into two similar sized paddocks. Acquired resistance to gastrointestinal nematodes was evaluated by faecal egg counts and weight gains. Again, pasture infection levels were determined and pepsinogen and antibody levels were measured. During the first grazing seasons gastrointestinal nematode infections were controlled very effectively by the bolus, as shown by the greater weight gains, the negligible faecal egg counts and the low serum pepsinogen and antibody levels in the treated calves. In contrast, all parameters showed extensive parasite-host contact in the untreated animals. The efficient prophylaxis in the treated groups resulted in low levels of larval contamination on the paddocks grazed by the treated animals, compared to moderate infection levels at the end of both first grazing seasons on the paddocks grazed by the untreated animals. During the second grazing seasons (1994 and 1995) the faecal egg output was low in all groups. Although in the previously treated animals faecal egg counts were consistently higher, the differences were minimal, resulting in comparable levels of larval contamination on both paddocks. Serum pepsinogen and antibody levels were not significantly different between the groups and indicated a similar level of larval uptake on both paddocks. No negative effect of the previous chemoprophylaxis on the clinical condition and the weight gain of the second season grazing animals was observed.


Assuntos
Anti-Helmínticos/uso terapêutico , Doenças dos Bovinos/prevenção & controle , Enteropatias Parasitárias/veterinária , Ivermectina/uso terapêutico , Infecções por Nematoides/veterinária , Animais , Anti-Helmínticos/administração & dosagem , Bovinos , Doenças dos Bovinos/tratamento farmacológico , Quimioprevenção/veterinária , Preparações de Ação Retardada , Feminino , Interações Hospedeiro-Parasita , Imunoglobulina G/análise , Enteropatias Parasitárias/prevenção & controle , Ivermectina/administração & dosagem , Infecções por Nematoides/prevenção & controle , Ostertagia/imunologia , Ostertagia/parasitologia , Contagem de Ovos de Parasitas , Pepsinogênios/análise , Pepsinogênios/sangue , Testes Sorológicos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA